Originally published on JeffereyJaxen.com.
Piece by piece the foundation and historical legacy of the Human Papilloma Virus (HPV) vaccine is fast approaching the reality anticipated by former pharmaceutical industry physician with Gardasil manufacturers Merck when he stated in 2014, “I predict that Gardasil will become the greatest medical scandal of all times…”
In Europe, the ‘safe and effective’ HPV misinformation appears to have run its course. Receiving no coverage by mainstream media sources, the Nordic Cochrane Centre has filed its second complaint in five months – this time to the European ombudsman – over maladministration at the European Medicines Agency (EMA) in relation to the safety of the HPV vaccines.
According to the Nordic Cochrane Centre, its first complaint to the EMA filed on May 26, 2016 was met with replies that did not fully address their concerns. The Centre writes in its new complaint that,
“Some of our concerns were not addressed at all, and several of the EMA’s statements were either wrong or seriously misleading, or irrelevant for the criticism we had posed. We therefore now complain to the EU ombudsman over the EMA.”
This time around, the Nordic Cochrane Centre’s complaint is joined by support from other major European institutions.
The recent complaint outlines 19 points of contention and issues with the EMA’s procedures, conflicts of interest, secrecy and unprofessionalism concerning their handling of HPV data, research and whistleblowers. What many in the public and private sectors have warned for years – the relationship between regulators, researchers and the pharmaceutical industry – was once again confirmed. The Centre’s complaint states
“…experts who had declared current direct interests in a pharmaceutical company or for a particular medicinal product were allowed to participate in the Scientific Advisory Group meeting.”
Specifically, a particularly glaring conflict of interest was summarized by the Centre as they stated:
“There were no restrictions for the chair of the meeting, Andrew Pollard, although he had declared several conflicts of interest in relation to the HPV vaccine manufacturers GlaxoSmithKline and Sanofi Pasteur MSD until 2014 and 2013, respectively.”
In the current and historical atmosphere of medical secrecy, government red tape and uncertainty around the integrity of pharmaceutically-sponsored vaccine research, it was refreshing for a prominent organization like the Nordic Cochrane Centre to counter accepted establishment positions by stating,
“We don’t have confidence that the agency [EMA] has interpreted these documents in a way that ensures openness, gives the administration legitimacy, makes it accountable to the citizens, and respects fundamental rights of access to information that is important for the citizens when they make decisions about healthcare…”